Latest journalAll journals
EMJ Cardiology 11 [Supplement 1] 2023
Amyloid light-chain (AL) amyloidosis is a rare systemic disease caused by plasma cell dyscrasia. These plasma cells produce excess Ig light chains, which can misfold, aggregate, and deposit in tissues, resulting in toxicity and organ dysfunction. The heart is among the most commonly affected organs and cardiac involvement is associated with significantly worse outcomes.
Latest articlesAll articles
Hearts are NOT Made to Be Broken: Expert Opinion on Amyloid Light-Chain Cardiac Amyloidosis
Caseous Mitral Annular Calcification Presenting as Retinal Artery Occlusion
Congress reviewsAll congress reviews
Review of the European Society of Cardiology (ESC) Congress 2022
AFTER 2 years of virtual meetings, the European Society of Cardiology (ESC) adopted a pioneering hybrid format for its 2022 congress, allowing delegates from across the globe to meet onsite in Barcelona, Spain, and also online. Clinicians and academics came together with one common goal: to advance cardiovascular care and improve patient outcomes.
The Future of Cardiovascular Medicine: From 2022 to 2033
In a session presented at this year’s European Society of Cardiology (ESC) Congress, which was held in-person in Barcelona, Spain, and virtually, experts discussed their future predictions for cardiovascular health and innovations that will enter this field.
Latest NewsAll News
Latest PodcastsAll Podcasts
14th July 2022
Recommendations For Better Patient Outcomes in LDL-C Management
This EMJ podcast explores the vital topic of low-density lipoprotein cholesterol (LDL-C) management in relation to the treatment and prevention of atherosclerotic cardiovascular disease. Our host, George Cooper, is joined by Michal Vrablík.